Aqr Capital Management LLC Zynerba Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 17, 2020
SELL
$3.31 - $6.54 $90,108 - $178,038
-27,223 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$2.9 - $6.16 $7,325 - $15,560
2,526 Added 10.23%
27,223 $104,000
Q4 2019

Feb 14, 2020
BUY
$5.61 - $8.57 $58,315 - $89,085
10,395 Added 72.68%
24,697 $149,000
Q3 2019

Nov 14, 2019
BUY
$7.56 - $15.44 $108,123 - $220,822
14,302 New
14,302 $108,000

Others Institutions Holding ZYNE

# of Institutions
4
Shares Held
774K
Call Options Held
0
Put Options Held
0
View Full List

About Zynerba Pharmaceuticals, Inc.

ZYNE Quotes by TradingView
  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email